{"id":"NCT01485614","sponsor":"Merck Sharp & Dohme LLC","briefTitle":"Study to Assess Safety & Efficacy of Sitagliptin as Initial Oral Therapy for Treatment of Type 2 Diabetes Mellitus in Pediatric Participants. (MK-0431-083)","officialTitle":"A Phase III, Multicenter, Double-Blind, Randomized, Placebo-Controlled Clinical Trial to Evaluate the Safety and Efficacy of Sitagliptin in Pediatric Patients With Type 2 Diabetes Mellitus With Inadequate Glycemic Control","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2012-02-10","primaryCompletion":"2019-10-09","completion":"2019-10-09","firstPosted":"2011-12-05","resultsPosted":"2020-12-16","lastUpdate":"2022-09-23"},"enrollment":200,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Diabetes Mellitus","Type 2 Diabetes"],"interventions":[{"type":"DRUG","name":"Sitagliptin","otherNames":["Januvia®, Tesavel®, Xelevia®, Ristaben®, Glactiv®"]},{"type":"DRUG","name":"Metformin","otherNames":["Glucophage®, Metgluco®, Glycoran®"]},{"type":"DRUG","name":"Placebo to sitagliptin","otherNames":[]},{"type":"DRUG","name":"Placebo to metformin","otherNames":[]},{"type":"DRUG","name":"Glycemic Rescue 1","otherNames":[]},{"type":"BIOLOGICAL","name":"Glycemic Rescue 2","otherNames":[]}],"arms":[{"label":"Sitagliptin","type":"EXPERIMENTAL"},{"label":"Placebo/Metformin","type":"PLACEBO_COMPARATOR"},{"label":"Metformin","type":"ACTIVE_COMPARATOR"},{"label":"Placebo/Sitagliptin","type":"PLACEBO_COMPARATOR"}],"summary":"The purpose of the study is to assess the safety of the addition of sitagliptin, and its effect on hemoglobin A1c (A1C) in pediatric participants 10-17 years of age with type 2 diabetes mellitus (T2DM) with inadequate glycemic control. The primary hypothesis for this study is that sitagliptin reduces A1C more than placebo after 20 weeks of treatment.","primaryOutcome":{"measure":"Change From Baseline in Hemoglobin A1C (A1C) at Week 20","timeFrame":"Baseline and Week 20","effectByArm":[{"arm":"Sitagliptin","deltaMin":-0.13,"sd":1.58},{"arm":"Placebo/Metformin","deltaMin":-0.02,"sd":1.45},{"arm":"Metformin","deltaMin":-1.03,"sd":0.72},{"arm":"Placebo/Sitagliptin","deltaMin":0.57,"sd":1.62}],"pValues":[]},"eligibility":{"minAge":"10 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":3,"exclusionCount":23},"locations":{"siteCount":0,"countries":[]},"refs":{"pmids":["34779087"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":10,"n":95},"commonTop":["Hypoglycaemia","Upper respiratory tract infection","Headache","Diarrhoea","Nasopharyngitis"]}}